Published in Hepatitis Weekly, October 2nd, 2006
"This study investigates the correlation of HPC expression with treatment response in patients with chronic hepatitis C. The study comprised 77 liver biopsies with chronic HCV," wrote A.C. Tsamandas and colleagues, Patras University Hospital.
"All patients were PCR-HCV+ and received antiviral therapy with interferon or pegylated interferon alpha-2b and ribavirin. Twenty-nine patients were assigned as responders (group A), 29 as nonresponders (group B) and 19 as...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.